Online Only Articles

A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis

Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Department of Chemistry, University of Florida, Gainesville, FL, USA
Department of Chemistry, University of Florida, Gainesville, FL, USA;UF-Health Cancer Center, University of Florida, Gainesville, FL, USA
UF-Health Cancer Center, University of Florida, Gainesville, FL, USA;Department of Pharmacology & Therapeutics, University of Florida, Gainesville, FL, USA
Experimental Oncology and Hematology, Department of Oncology and Hematology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
Vol. 104 No. 9 (2019): September, 2019 https://doi.org/10.3324/haematol.2018.207704